Edition:
United Kingdom

Medigene AG (MDG1k.DE)

MDG1k.DE on Xetra

7.64EUR
14 Dec 2018
Change (% chg)

€-0.22 (-2.86%)
Prev Close
€7.86
Open
€7.91
Day's High
€7.91
Day's Low
€7.57
Volume
119,811
Avg. Vol
161,417
52-wk High
€19.42
52-wk Low
€7.43

Chart for

About

Medigene AG is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-based immunotherapies. It develops three platforms: T-cell receptor (TCR)-modi... (more)

Overall

Beta: 1.27
Market Cap(Mil.): €287.57
Shares Outstanding(Mil.): 22.30
Dividend: --
Yield (%): --

Financials

  MDG1k.DE Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -0.81 -- --
ROI: -15.86 9.01 14.96
ROE: -18.62 10.15 16.52

BRIEF -Medigene Raises 2018 Guidance After H1 Results

* NOW EXPECTS TO GENERATE TOTAL 2018 REVENUE OF BETWEEN EUR 9.5 - 10.5 MILLION

07 Aug 2018

Earnings vs. Estimates